Balyasny Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37,977
Closed -$316K 3036
2025
Q4
$316K Sell
37,977
-59,941
-61% -$645K ﹤0.01% 2708
2025
Q3
$1.43M Buy
+97,918
New +$1.17M ﹤0.01% 1969
2025
Q2
Sell
-169,343
Closed -$965K 2955
2025
Q1
$965K Buy
169,343
+88,600
+110% +$903K ﹤0.01% 2004
2024
Q4
$793K Buy
80,743
+59,334
+277% +$509K ﹤0.01% 2032
2024
Q3
$174K Buy
21,409
+8,317
+64% +$83.3K ﹤0.01% 2589
2024
Q2
$175K Buy
+13,092
New +$391K ﹤0.01% 2356
2023
Q4
Sell
-786
Closed -$56.9K 2568
2023
Q3
$56.9K Sell
786
-20,852
-96% -$1.67M ﹤0.01% 2154
2023
Q2
$1.61M Buy
21,638
+10,171
+89% +$602K ﹤0.01% 1445
2023
Q1
$610K Buy
11,467
+10,490
+1,074% +$665K ﹤0.01% 1900
2022
Q4
$66K Buy
+977
New +$89.9K ﹤0.01% 2310

Other funds holding DNA